Now 33, Stephenson was one of the first to receive sickle cell gene therapy in a clinical trial six years ago. Before the treatment, Stephenson lived her life on a razor's edge.

Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would advance one day.

By Dec. 20, the FDA will determine the fate of a second gene therapy for people with sickle cell, lovo-cel by Bluebird Bio, which relies on a more established approach to gene therapy.

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

How Sickle Cell Gene Therapy Works. The idea behind sickle cell gene therapy is that a person would receive some sort of gene that would allow their red blood cells to function normally.

Gene therapy caused some disasters early on, but it's finally started to work, and several experimental gene therapies are showing promise for sickle cell disease now. MARTIN: Well, how so?

Expert joins CBS New York to discuss new sickle cell treatment 02:46. Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that ...

The treatment, however, also sparks mixed feelings among both Black sickle cell patients and doctors, who are concerned about potential side effects, costs and access to the therapy, will cost $2. ...

Every year, approximately 2,000 babies are diagnosed with sickle cell disease at birth. While the exact number of people ...

Kendric Cromer, 12, the first commercial patient for Bluebird Bio’s gene therapy to cure his sickle cell disease, in the hospital as his bone marrow stem cells were being removed for gene editing.

Now, 33, Stephenson was one of the first to receive sickle cell gene therapy in a clinical trial six years ago. Before the treatment, Stephenson lived her life on a razor's edge.